IDiyas

For the Inventor, By the Inventor

Allschwil, Switzerland

Christoph Boss

USPTO Granted Patents = 59 

 

 

Average Co-Inventor Count = 5.6

ph-index = 10

Forward Citations = 266(Granted Patents)


Inventors with similar research interests:


Company Filing History:

goldMedal43 out of 217 
 
Actelion Pharmaceuticals Ltd
 patents
silverMedal16 out of 77 
 
Idorsia Pharmaceuticals Ltd
 patents

Years Active: 2003-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pyrimidine Derivatives
PGE2 Receptor Modulators
Benzimidazole-Proline Derivatives
NADPH Oxidase Inhibitors
Azaindole Acetic Acid Derivatives
Orexin Receptor Antagonists
Prostaglandin D2 Receptor Modulators
Antimalarial Agents
Heterocyclyl Derivatives
Lactam Derivatives
Piperazine Derivatives
Thiazolidine Derivatives
59 patents (USPTO):Explore Patents
1. 11839613 - Pyrimidine derivatives as PGE2 receptor modulators (2023-12-12),
2. 11712438 - Phenyl derivatives as PGE2 receptor modulators (2023-08-01),
3. 11446298 - Pyrimidine derivatives (2022-09-20),
4. 11325899 - Benzofurane and benzothiophene derivatives as PGE2 receptor modulators (2022-05-10),
5. 11267824 - Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenase (2022-03-08),
6. 11136317 - NADPH oxidase 4 inhibitors (2021-10-05),
7. 11040966 - Benzimidazole-proline derivatives (2021-06-22),
8. 10584118 - NADPH oxidase 4 inhibitors (2020-03-10),
9. 10351560 - Crystalline forms (2019-07-16),
10. 10329287 - Benzimidazole-proline derivatives (2019-06-25),
11. 10301309 - Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators (2019-05-28),
12. 10023560 - Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist (2018-07-17),
13. 9914721 - Use of benzimidazole-proline derivatives (2018-03-13),
14. 9914720 - Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists (2018-03-13),
15. 9879006 - [object Object] (2018-01-30),

Title: The Innovative Journey of Christoph Boss

Introduction:

Christoph Boss, a visionary inventor hailing from Allschwil, Switzerland, has made significant contributions to the world of technology and innovation.

Latest Patents:

Christoph Boss holds several patents in the field of biotechnology, with his most recent inventions focusing on advanced drug delivery systems and personalized medicine.

Career Highlights:

With a background in bioengineering, Christoph Boss has dedicated his career to developing cutting-edge solutions for healthcare challenges. His work has been instrumental in revolutionizing the way medications are administered and personalized for patients.

Collaborations:

Throughout his career, Christoph Boss has collaborated with leading pharmaceutical companies, research institutions, and universities to bring his inventions to life. His collaborative spirit has led to groundbreaking advancements in the field of biotechnology.

Conclusion:

In conclusion, Christoph Boss stands as a beacon of innovation in the field of biotechnology, with a passion for improving healthcare outcomes through his groundbreaking inventions. His dedication to pushing the boundaries of what is possible continues to inspire the next generation of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…